CDNA241220P35000
- 0.00
- 0.000.00%
CareDx Newsroom
Higher-Than-Anticipated Reimbursement Rates Lifted CareDx (CDNA)
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Wall Street Analysts Predict a 49.89% Upside in CareDx (CDNA): Here's What You Should Know
Transplant Therapeutics Consortium Receives FDA Acceptance of the Qualification Plan for IBox Scoring System
After Plunging -11.97% in 4 Weeks, Here's Why the Trend Might Reverse for CareDx (CDNA)
CareDx Management to Meet With Craig Hallum
CareDx to Participate in Upcoming Investor Conferences
Accelerated Testing Volume Lifted CareDx (CDNA) in Q3
Q3 2024 CareDx Inc Earnings Call
Earnings Call: CareDx Sees Robust Growth in Q3, Raises FY 2024 Outlook
Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating, Announces Target Price $40
CareDx, Inc's (NASDAQ:CDNA) 26% Dip In Price Shows Sentiment Is Matching Revenues
BTIG Maintains CareDx(CDNA.US) With Buy Rating, Cuts Target Price to $35
H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
CareDx: Strong Financial Performance and Strategic Positioning Support Buy Rating Amid Positive Long-Term Growth Prospects
Express News | CareDx Inc : Btig Cuts Target Price to $35 From $40
CareDx Inc (CDNA) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...
CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript Summary
CareDx: Q3 Earnings Snapshot
CareDx Non-GAAP EPS of $0.14 Beats by $0.13, Revenue of $82.88M Beats by $2.17M